Defilade Capital Management »

Evommune shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $16M 679k 22.99

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune